Total 2 articles
FDA approval looms for psilocybin depression treatment showing 39% success rate. But are we ready to embrace psychedelics as medicine?
Novo Nordisk (NVO) stock jumped 8% following FDA approval for the oral pill version of its weight-loss drug Wegovy. The move is expected to significantly broaden patient access and intensify competition with Eli Lilly.
Advertise with Us